Omega-3 polyunsaturated fatty acids as a treatment strategy for nonalcoholic fatty liver disease

Cites (218)

Items 201–216 of 216

1. Serum Intercellular Adhesion Molecule‐1 in Patients With Nonalcoholic Steatohepatitis: Comparison With Alcoholic Hepatitis
   Shuji Ito, Toyokazu Yukawa, Shinichiro Uetake, Masayoshi Yamauchi · 2007 · Alcoholism Clinical and Experimental Research
2. Efficacy and safety of prescription omega-3-acid ethyl esters for the prevention of recurrent symptomatic atrial fibrillation: A prospective study
   Craig M. Pratt, James A. Reiffel, Kenneth A. Ellenbogen, Gerald V. Naccarelli, Peter Russell Kowey · 2009 · American Heart Journal
3. Highly Purified Eicosapentaenoic Acid Ethyl Ester Prevents Development of Steatosis and Hepatic Fibrosis in Rats
   Satoshi Kajikawa, Tsuyoshi Harada, Akiko Kawashima, Kazunori Imada, Kiyoshi Mizuguchi · 2009 · Digestive Diseases and Sciences
4. Low Docosahexaenoic Acid Content in Plasma Phospholipids is Associated with Increased Non‐alcoholic Fatty Liver Disease in China
   Ju‐Sheng Zheng, Amei Xu, Tao Huang, Xiaomei Yu, Duo Li · 2012 · Lipids
5. From the liver to the heart: Cardiac dysfunction in obese children with non-alcoholic fatty liver disease
   Anna Di Sessa, Giuseppina Rosaria Umano, Emanuele Miraglia del Giudice, Nicola Santoro · 2017 · World Journal of Hepatology
6. A Lipidomic Analysis of Docosahexaenoic Acid (22:6, ω3) Mediated Attenuation of Western Diet Induced Nonalcoholic Steatohepatitis in Male Ldlr -/- Mice
   Manuel García‐Jaramillo, Kelli A. Lytle, Melinda H. Spooner, Donald Β. Jump · 2019 · Metabolites
7. Fructose-induced stress signaling in the liver involves methylglyoxal
   Yuren Wei, Dong Wang, Gretchen Moran, Andrea L. Estrada, Michael J. Pagliassotti · 2013 · Nutrition & Metabolism
8. Genetics of non-alcoholic fatty liver disease: From susceptibility and nutrient interactions to management
   Vishnubhotla Venkata Ravi Kanth, Mitnala Sasikala, Mithun Sharma, Padaki Nagaraja Rao, D. Nageshwar Reddy · 2016 · World Journal of Hepatology
9. Serum phospholipid omega-3 polyunsaturated fatty acids and insulin resistance in type 2 diabetes mellitus and non-alcoholic fatty liver disease
   Da-jun Lou, Qi-qian Zhu, Xu-wei Si, Li-li Guan, Qiao-ying You, Zhongming Yu, Aizhen Zhang, Duo Li · 2014 · Journal of Diabetes and its Complications
10. Hepatic Fatty Acid Composition Differs between Chronic Hepatitis C Patients with and without Steatosis
    Bianca Maria Arendt, Saira S. Mohammed, Elaheh Aghdassi, Nita Rosalinda Prayitno, David W.L., Augustin Nguyen, Maha M. Guindi, Morris Sherman, E. Jenny Heathcote, Johane P. Allard · 2009 · Journal of Nutrition
11. Endotoxin in the gut and chylomicrons: translocation or transportation?
    Carl Grünfeld, Kenneth R. Feingold · 2008 · Journal of Lipid Research
12. Icosabutate Exerts Beneficial Effects Upon Insulin Sensitivity, Hepatic Inflammation, Lipotoxicity, and Fibrosis in Mice
    Anita M. van den Hoek, Elsbet Jantine Pieterman, José W. van der Hoorn, Marta Iruarrizaga‐Lejarreta, Cristina Alonso, Lars Verschuren, Tore Skjæret, Hans M. G. Princen, David A. Fraser · 2019 · Hepatology Communications
13. The liver's weighty problem
    Mitch Leslie · 2015 · Science
14. Debate: A bridge too far—liver transplantation for nonalcoholic steatohepatitis will overwhelm the organ supply
    Julie K. Heimbach · 2014 · Liver Transplantation
15. Histological features of non‐alcoholic fatty liver disease: What is important?
    Etsuko Hashimoto, Katsutoshi Tokushige, Geoffrey C. Farrell · 2011 · Journal of Gastroenterology and Hepatology
16. Docosahexaenoic Acid Levels in Blood and Metabolic Syndrome in Obese Children: Is There a Link?
    Carlotta Lassandro, Giuseppe Banderali, Giovanni Radaelli, Elisa Borghi, Francesca Moretti, Elvira Verduci · 2015 · International Journal of Molecular Sciences